Drugs by condition
Drugs approved for spinal muscular atrophy
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
4
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
3
New molecular entities and new biologics
In development
6
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for spinal muscular atrophy.
All approved drugs for spinal muscular atrophy, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Drugs in development for spinal muscular atrophy
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- RO7204239Phase 33 trials
Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity
- SalanersenBIIB115Phase 33 trials
Biogen · Muscular Atrophy, Spinal, Spinal Muscular Atrophy
- BHV-2000Taldefgrobep, BMS-986089Phase 32 trials
Biohaven Pharmaceuticals, Inc. · Spinal Muscular Atrophy, Neuromuscular Diseases, SMA
- NMD670Phase 23 trials
NMD Pharma A/S · Myasthenia Gravis, Myasthenia Gravis, MuSK, Charcot-Marie-Tooth Disease
- ARGX-119Phase 21 trial
argenx · Spinal Muscular Atrophy (SMA)
- GB221Phase 21 trial
Gemma Biotherapeutics · Spinal Muscular Atrophy Type I
More on spinal muscular atrophy: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Duchenne muscular dystrophy · Huntington's disease chorea · Tardive dyskinesia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.